mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.03 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.03 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.03 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.03 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.03 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |